These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28616776)

  • 1. Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients.
    Papadima EM; Niola P; Melis C; Pisanu C; Congiu D; Cruceanu C; Lopez JP; Turecki G; Ardau R; Severino G; Chillotti C; Del Zompo M; Squassina A
    J Mol Neurosci; 2017 Aug; 62(3-4):304-308. PubMed ID: 28616776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary Transcriptome Analysis in Lymphoblasts from Cluster Headache and Bipolar Disorder Patients Implicates Dysregulation of Circadian and Serotonergic Genes.
    Costa M; Squassina A; Piras IS; Pisanu C; Congiu D; Niola P; Angius A; Chillotti C; Ardau R; Severino G; Stochino E; Deidda A; Persico AM; Alda M; Del Zompo M
    J Mol Neurosci; 2015 Jul; 56(3):688-95. PubMed ID: 25912293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.
    Squassina A; Costa M; Congiu D; Manchia M; Angius A; Deiana V; Ardau R; Chillotti C; Severino G; Calza S; Del Zompo M
    Pharmacol Res; 2013 Jul; 73():1-7. PubMed ID: 23619527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.
    Squassina A; Pisanu C; Congiu D; Caria P; Frau D; Niola P; Melis C; Baggiani G; Lopez JP; Cruceanu C; Turecki G; Severino G; Bocchetta A; Vanni R; Chillotti C; Del Zompo M
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1241-7. PubMed ID: 27084304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy.
    Milanesi E; Voinsky I; Hadar A; Srouji A; Maj C; Shekhtman T; Gershovits M; Gilad S; Chillotti C; Squassina A; Potash JB; Schulze TG; Goes FS; Zandi P; Kelsoe JR; Gurwitz D
    World J Biol Psychiatry; 2019 Jul; 20(6):449-461. PubMed ID: 28854847
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder.
    Fries GR; Colpo GD; Monroy-Jaramillo N; Zhao J; Zhao Z; Arnold JG; Bowden CL; Walss-Bass C
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1110-1119. PubMed ID: 28939162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
    Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
    Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders.
    Moreira J; Courtin C; Geoffroy PA; Curis E; Bellivier F; Marie-Claire C
    Psychiatry Res; 2017 May; 251():217-220. PubMed ID: 28214779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium response in bipolar disorder correlates with improved cell viability of patient derived cell lines.
    Paul P; Iyer S; Nadella RK; Nayak R; Chellappa AS; Ambardar S; Sud R; Sukumaran SK; Purushottam M; Jain S; ; Viswanath B
    Sci Rep; 2020 May; 10(1):7428. PubMed ID: 32366893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment.
    Squassina A; Meloni A; Congiu D; Bosganas P; Patrinos GP; Lin R; Turecki G; Severino G; Ardau R; Chillotti C; Pisanu C
    Hum Genomics; 2022 Oct; 16(1):45. PubMed ID: 36253798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients.
    Milanesi E; Hadar A; Maffioletti E; Werner H; Shomron N; Gennarelli M; Schulze TG; Costa M; Del Zompo M; Squassina A; Gurwitz D
    J Mol Neurosci; 2015 Jul; 56(3):681-7. PubMed ID: 25740013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mRNA expression of peripheral glial cell markers in bipolar disorder: The effect of long-term lithium treatment.
    Ferensztajn-Rochowiak E; Tarnowski M; Samochowiec J; Michalak M; Ratajczak MZ; Rybakowski JK
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1516-1521. PubMed ID: 27474686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients.
    Mizrahi L; Choudhary A; Ofer P; Goldberg G; Milanesi E; Kelsoe JR; Gurwitz D; Alda M; Gage FH; Stern S
    Mol Psychiatry; 2023 Oct; 28(10):4280-4293. PubMed ID: 37488168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium response in bipolar disorders and core clock genes expression.
    Geoffroy PA; Curis E; Courtin C; Moreira J; Morvillers T; Etain B; Laplanche JL; Bellivier F; Marie-Claire C
    World J Biol Psychiatry; 2018 Dec; 19(8):619-632. PubMed ID: 28095742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
    Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients.
    McCarthy MJ; Wei H; Landgraf D; Le Roux MJ; Welsh DK
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1310-9. PubMed ID: 27216486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel integrative genomic tool for interrogating lithium response in bipolar disorder.
    Hunsberger JG; Chibane FL; Elkahloun AG; Henderson R; Singh R; Lawson J; Cruceanu C; Nagarajan V; Turecki G; Squassina A; Medeiros CD; Del Zompo M; Rouleau GA; Alda M; Chuang DM
    Transl Psychiatry; 2015 Feb; 5(2):e504. PubMed ID: 25646593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder.
    Kittel-Schneider S; Hilscher M; Scholz CJ; Weber H; Grünewald L; Schwarz R; Chiocchetti AG; Reif A
    World J Biol Psychiatry; 2019 Jul; 20(6):462-475. PubMed ID: 29067888
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers.
    Willmroth F; Drieling T; Lamla U; Marcushen M; Wark HJ; van Calker D
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):63-71. PubMed ID: 16420717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.